Design of a study to determine the impact of insecticide resistance on malaria vector control: a multi-country investigation
- Immo Kleinschmidt1, 24Email author,
- Abraham Peter Mnzava9,
- Hmooda Toto Kafy2,
- Charles Mbogo5,
- Adam Ismail Bashir3, 4,
- Jude Bigoga6,
- Alioun Adechoubou7,
- Kamaraju Raghavendra8,
- Tessa Bellamy Knox9,
- Elfatih M Malik14,
- Zinga José Nkuni9,
- Nabie Bayoh10,
- Eric Ochomo10,
- Etienne Fondjo11,
- Celestin Kouambeng11,
- Herman Parfait Awono-Ambene12,
- Josiane Etang12, 22,
- Martin Akogbeto19,
- Rajendra Bhatt8,
- Dipak K Swain8,
- Teresa Kinyari16,
- Kiambo Njagi17,
- Lawrence Muthami18,
- Krishanthi Subramaniam13,
- John Bradley1,
- Philippa West1,
- Achile Massougbodji23,
- Mariam Okê-Sopoh7,
- Aurore Hounto23,
- Khalid Elmardi2,
- Neena Valecha8,
- Luna Kamau20,
- Evan Mathenge21 and
- Martin James Donnelly13, 15
© Kleinschmidt et al. 2015
Received: 7 February 2015
Accepted: 28 June 2015
Published: 22 July 2015
Progress in reducing the malaria disease burden through the substantial scale up of insecticide-based vector control in recent years could be reversed by the widespread emergence of insecticide resistance. The impact of insecticide resistance on the protective effectiveness of insecticide-treated nets (ITN) and indoor residual spraying (IRS) is not known. A multi-country study was undertaken in Sudan, Kenya, India, Cameroon and Benin to quantify the potential loss of epidemiological effectiveness of ITNs and IRS due to decreased susceptibility of malaria vectors to insecticides. The design of the study is described in this paper.
Malaria disease incidence rates by active case detection in cohorts of children, and indicators of insecticide resistance in local vectors were monitored in each of approximately 300 separate locations (clusters) with high coverage of malaria vector control over multiple malaria seasons. Phenotypic and genotypic resistance was assessed annually. In two countries, Sudan and India, clusters were randomly assigned to receive universal coverage of ITNs only, or universal coverage of ITNs combined with high coverage of IRS. Association between malaria incidence and insecticide resistance, and protective effectiveness of vector control methods and insecticide resistance were estimated, respectively.
Cohorts have been set up in all five countries, and phenotypic resistance data have been collected in all clusters. In Sudan, Kenya, Cameroon and Benin data collection is due to be completed in 2015. In India data collection will be completed in 2016.
The paper discusses challenges faced in the design and execution of the study, the analysis plan, the strengths and weaknesses, and the possible alternatives to the chosen study design.
Reductions in malaria disease burden, as documented in recent World Malaria Reports [1, 2], have coincided with the massive scale-up of malaria prevention measures, of which vector control was the predominant component, particularly in sub-Saharan Africa. The core malaria vector control interventions are insecticide-treated nets (ITNs) and indoor residual spraying (IRS), both of which deploy insecticides to kill malaria-transmitting mosquitoes. In populations at risk of malaria in sub-Saharan Africa, the proportion of households owning at least one ITN increased from 3% in 2000 to 67% in 2013, with the proportion of the population sleeping under a net increasing from 2 to 44% over the same period. In 2014, the number of ITNs delivered in the region was projected to reach 214 million. The proportion of the population at risk of malaria in the WHO African region who were protected by IRS, increased from 5% in 2005 to 11% in 2011, but fell to 7% in 2013, possibly in response to having to spray more expensive insecticides required for the management of insecticide resistance . Globally 3.5% of populations at risk of malaria were protected by IRS in 2013.
Whilst these substantial efforts have had a major impact on malaria disease burden, the global burden of malaria is still unacceptably high. Worldwide there were an estimated 584,000 malaria deaths and 198 million malaria cases in 2013. However, malaria mortality rates fell by 47% and malaria cases per 1,000 persons at risk declined by 30% between 2000 and 2013. In Africa malaria infection prevalence in children aged 2–10 years reduced continent-wide from 26% in 2000 to 14% in 2013, whilst prevalence in countries with stable transmission fell from 35 to 18% over the same period . Individual studies suggest that reductions in malaria incidence and infection prevalence have often occurred in the wake of the introduction or scale-up of vector control interventions [4–6].
These successes are now being threatened by the widespread emergence of insecticide resistance, especially in sub-Saharan Africa and India . Resistance to pyrethroids, which is currently the only insecticide class used in ITNs, is now ubiquitous in major vectors of malaria on the African continent. Resistance to insecticides that belong to the other three chemical classes used for IRS is emerging in many regions where insecticides are used for vector control [7–9].
The Global Plan for Insecticide Resistance Management in Malaria Vectors  sets out the strategies that countries should employ to monitor and manage insecticide resistance. Whilst there is extensive evidence of resistance in Anopheles mosquitoes, there is little evidence of control programme failure associated directly with insecticide resistance largely because of many confounding factors. In KwaZulu-Natal, South Africa, a sharp increase in malaria cases from <5,000 to approximately 50,000 cases per year in the 1990s coincided with a switch in IRS insecticide from DDT to the pyrethroid deltamethrin . Insecticide susceptibility tests showed that there was resistance to pyrethroids in Anopheles funestus, a vector that was previously driven to near extinction in KwaZulu-Natal . A change in policy that re-introduced IRS with DDT in 2000 was followed by a rapid decline in cases which was maintained in subsequent years. This example is a powerful reminder of the damage that can be caused by failing insecticides, particularly if insecticide policy is not based on appropriate susceptibility testing. Although this example constitutes the strongest indication of malaria operational programme failure resulting from insecticide resistance, it is somewhat undermined by the simultaneous switch from sulfadoxine/pyrimethamine (SP) to artemether/lumefantrine as a first-line drug in 2001, due to documented drug resistance to SP in Plasmodium falciparum .
Another cited example of apparent malaria control failure due to insecticide resistance is Bioko Island, Equatorial Guinea, where IRS with deltamethrin was used against Anopheles gambiae s.s. which harboured a kdr mutation often associated with pyrethroid resistance . However, subsequent detailed analyses of locality by locality disaggregation of available data cast doubt on the initial interpretation [5, 14]. A recent review  concluded that regardless of pyrethroid resistance, ITNs are superior to untreated nets in terms of mosquito mortality in semi-field hut trials and laboratory cone bio-assays.
These examples do not suggest that insecticide resistance does not pose a substantial and real threat to malaria vector control, but rather they demonstrate how difficult it is to assess the evidence of epidemiological impact of insecticide resistance when relying on historical data. To address this, a multi-country prospective study to assess the impact of insecticide resistance on the effectiveness of long lasting insecticidal nets (LLINs) and IRS was initiated in five countries, namely Benin, Cameroon, India, Kenya and Sudan, co-ordinated by the World Health Organization (WHO) and with primary funding from the Bill and Melinda Gates Foundation. This paper describes the design that was adopted for conducting this study.
To determine the impact of insecticide resistance in malaria vectors on the protective effectiveness of ITNs and IRS and hence on malaria disease burden;
To assess trends in the insecticide resistance status and underlying mechanisms in the main malaria vector species from the study areas in response to different interventions.
IR was characterized in the mosquito populations to which human populations, in whom disease burden was estimated, were exposed. Therefore IR assessments were made in mosquitoes caught in the neighbourhood of the human cohorts in which cases arose. As there was no way of knowing whether malaria cases were a result of bites from resistant or susceptible mosquitoes, information on resistance status of mosquitoes in the area was used as a proxy of individual exposure to infective IR mosquitoes. Any association between incident cases and the exposure was investigated at the level of a cluster (area). In this respect the study has an ecological study design.
In the study areas in the five countries, the impact of IR on epidemiological malaria outcomes in relation to the presence of insecticide-based interventions was assessed using one or both of the two approaches described below. The study was designed on the basis of use of LLINs at high coverage rates at all study sites in accordance with WHO policy .
The following explanation of the study design is in terms of ITNs as a vector control intervention since ITNs were used in all study sites. A similar elaboration is implied for IRS.
Loss of effectiveness can be quantified by comparing the effectiveness of ITNs in areas with resistant vectors to the effectiveness of ITNs in areas with susceptible vectors by taking the ratio of rate ratios (RR), (IITN,r/INoITN,r)/(IITN,s/INoITN,s) where the subscripts r and s refer to resistant and susceptible areas, respectively. This ratio ranges from 0 to 1, where the smaller the ratio the larger the loss of effectiveness in areas of resistance (with a value of 1 indicating no loss of effectiveness).
Ethically, a trial with a neutral control group that was not to receive a prevention measure (i.e., vector control) was unacceptable since it is known that these interventions are effective. This was also not a viable approach given that almost all communities in malaria-endemic countries now have a certain level of ITN coverage anyway. The two quantities INoITN,r and INoITN,s therefore cannot be measured.
However, it is reasonable to assume that IR will not cause an increase in malaria incidence in places where there is no insecticide-based vector control, if all other transmission factors are comparable. If susceptible vectors are more competent than resistant vectors, then INoITN,r ≤ INoITN,s. The two effects of resistance and vector competence in resistant vectors cannot be disentangled in this study; from the perspective of malaria vector control the combined impact of resistance and potentially reduced vector competence is of key importance; it is this combined impact that this study is designed to estimate.
The outcome measure for estimating loss of effectiveness would therefore be the ratio IITN,r/IITN,s where IITN,r and IITN,s refer to mean incidence in communities with ITNs where vectors are resistant and similar communities where vectors are susceptible, respectively. It is possible that areas with resistance and those without resistance may differ not just in their resistance status, but by other factors that are associated with malaria incidence. This would result in the two quantities that cannot be measured INoITN,r and INoITN,s being unequal. As far as is possible estimates of the impact of IR should be adjusted for such confounders if they are measurable.
Even though no randomization of the exposure (IR) was possible, a cluster design was used to generate as large a number of observations of malaria outcomes and IR as feasible, and thereby gain statistical power. Each cluster acted as an entomological and as an epidemiological sampling point. Clusters were chosen to be villages or groups of hamlets with at least 500 houses that were at least 2 km apart but with greater separation where possible . Households for the assessment of epidemiological outcomes were selected on the basis of close proximity to the habitats at which mosquitoes were collected for measurement of IR. In Sudan and India, clusters could be randomly allocated to receive either IRS in combination with ITNs, or ITNs alone. These two country studies had the advantage of allowing the assessment of the differential impact of resistance on the combination of interventions relative to a single intervention, and the evaluation of differences in temporal trends in resistance due to differences in selection pressure exerted by the combination relative to the single intervention.
Epidemiological outcomes, by country
Epidemiological outcome indicator
Clinical malaria incidence (fever plus infection)
Malaria case incidence by passive case detectiona
Active case detection by testing cohort children who are febrile or report recent fever
Active infection detection by testing cohort children at 2 weeks intervals
Malaria indicator surveys testing a randomly selected cross-section of children in study clusters
Passive case detection using clinic registers based on confirmed cases
The four epidemiological outcome indicators are described below.
Clinical malaria incidence from active case detection cohorts
Study implementation details by country
Active case detection: average cohort size per cluster; age group in years
Active infection detection: cohort size per cluster; age group in years
Cross sectional prevalence of infection (✔); sample per cluster; age range in years
Passive case detection from clinic registers (✔)
Statistical power assumptions
Number of clusters
140 (66 sentinel, randomly selected by study arm)
Active case detection incidence
Active case detection incidence
Active case detection incidence
Active case detection incidence
Active case detection incidence
Power; significance, ka
80%; 5%; 0.5
80%; 5%; 0.4
80%; 5%; 0.4
80%; 5%; 0.4
80%; 5%; 0.3
Minimum detectable difference in incidence between low and high resistance clusters/rate ratio high to low resistance
Assumed incidence in low resistance clusters; number of years follow-up
0.030 per annum; 3
1.4 per annum; 2
0.6 per annum; 2
1.4 per annum; 2
0.015 per annum; 2
Infection incidence in cohorts with repeated testing regardless of symptoms
In the three high-transmission countries, cohorts of children under 5 years of age were recruited in each cluster and visited fortnightly (see Table 2). At recruitment and following written consent, all children were given a treatment dose of the first-line anti-malarial drug for the particular country [either artemether/lumefantrine (AL) or artesunate/amodiaquine (ASAQ)], for clearance of any parasites. At the first visit following treatment (visit 1), a blood-slide was taken for microscopic examination to verify that children had been successfully cleared of parasites; those positive were treated or referred for treatment, and released from the cohort. The period between recruitment and visit 1 was not included as time at risk for the purpose of incidence calculations since children were assumed to be protected by the prophylactic effect of treatment. At subsequent visits, children were tested by RDT. In Cameroon and initially in Kenya only those having symptoms (febrile) were tested every second fortnightly visit whilst all children were tested at least monthly. Details of visits to health facilities which took place between scheduled health worker visits, were recorded. Once a child tested positive they were treated and left the cohort. A new active infection detection (AID) cohort was recruited each year at the start of the malaria season. Whether the child slept under an ITN the night before the visit was determined at each visit from the caregiver. The physical condition of nets was observed and recorded at the time of recruitment.
Prevalence of infection with Plasmodium parasites
Cross-sectional malaria indicator surveys were performed in each study cluster to determine prevalence of infection of malarial parasites in children. The frequency of surveys and the age range of children eligible for inclusion varied between countries. Generally, blood tests were performed by RDT; in Benin microscopic examination of blood films was carried out. Survey questionnaires were adapted from the standard RBM Monitoring and Evaluation Reference Group malaria indicator survey and included questions on ITN use . In Sudan, dried blood spots on filter paper were collected for PCR analysis on a subsample of specimens. For molecular analysis, P. falciparum, was detected using real-time PCR assays from blood spots .
Clinical malaria case incidence from passive case detection
Incidence of malaria could be determined by passive case detection if a reliable system for reporting outpatient cases was in place, if a policy of testing all children under five presenting with a fever for malarial parasites was adhered to, if no stock-outs of slides or rapid diagnostic tests (RDTs) occurred and if diagnosis of malaria was only made if the patient tested positive by RDT or microscopic blood-slide examination. In addition, the place of residence of reported cases had to be accurate enough to determine which study cluster the patient resided in. Passive case detection data were collected in Benin and India only, where these conditions were partially met. Passive case detection data were not used as a primary outcome indicator since their quality could not be guaranteed. Passive case detection served to supplement the more rigorously derived indicators.
In areas in which the insecticide in most ITNs was deltamethrin (for example PermaNet® 2.0), susceptibility tests were conducted with deltamethrin. In areas where ITNs were in use in which permethrin was the active ingredient (for example, Olyset® net), susceptibility tests were carried out using this insecticide.
Allelic frequency of the Vgsc-L104F (formerly kdr-west) and Vgsc-L1014S (formerly kdr-east) mutation in Anopheles arabiensis and/or An. gambiae s.s. was determined in samples of locally caught mosquitoes to provide a second measure of IR [26, 27]. The extent to which these mutations are associated with phenotypic resistance is variable and possibly location dependent [28, 29]. Resistance, whether phenotypic or genotypic, was observed as a continuous measure on a percentage scale.
Sample size considerations
For each country, a power calculation was performed to estimate a minimum difference in incidence or prevalence that could be detected between high and low resistance clusters, based on the total number of clusters that could be formed with reasonable separation distance between clusters, and in which separate assessments of IR could be made. For the purpose of sample size calculations it was assumed that there would be an equal number of low and high resistance clusters, i.e., that the clusters would be dichotomized based on median mosquito mortality. The total numbers of clusters for each country were as follows: Sudan (140), Kenya (50), Cameroon (38), Benin (32), India (80). Details for each country are given in Table 2.
Data capture and management systems were set up in each country by information technology specialists. The structure of databases was standardized across countries. In case detection cohorts, follow-up was censored (excluded) if visits were missed, but children “re-entered” follow-up if they were observed at subsequent visits. Missing resistance data for a cluster meant that the cluster could not be included in analysis for the particular year.
In each country ethics approval for the study was obtained from the relevant national research ethics committee. Participation in the study was voluntary and based on written informed consent by the participant, or the caregiver in the case of children.
Study settings by country
El Hoosh and Hag Abdalla (Gezira State); Galabat (Gedarif State); New Halfa (Kassala State)
Districts of Teso, Rachuonyo, Nyando and Bondo (Western Kenya)
Districts of Garoua, Pitoa and Mayo Oulo (North Region)
Districts of Ifangni, Sakété, Pobé and Kétou (Departement de Plateau)
Subdistrict of Keshkal (Kondagaon, Chhattisgarh)
Predominant malaria vectors
An. gambiae s.s., An. arabiensis and An funestus
An arabiensis, An. gambiae s.s. and An funestus
An. gambiae s.s.
Vector control Interventions
High coverage of LLINs (PermaNet 2.0) in all study clusters. In each study area half of clusters randomly allocated to receive additionally IRS with bendiocarbb, balanced by baseline kdr frequencies
High coverage of LLINs (PermaNet 2.0 and Olyset Net) in all clusters. Rachuonyo and Nyando received IRS with deltamethrin and lambda-cyhalothrin in 2012, but no IRS was carried out subsequently
High coverage of LLINs (PermaNet 2.0) in all clusters
High coverage of LLINs (primarily Olyset Net) in all clusters
High coverage of LLINs (PermaNet 2.0) in all clusters. Half of clusters randomly allocated to receive additionally IRS with bendiocarb
Baseline insecticide resistance (cluster-specific range)
Kdr frequency by cluster ranged from 8.3 to 70.8% (2010); WHO Bioassay mortality to deltamethrin in sentinel clusters ranged from 47 to 100% (2011)
Kdr frequency by cluster not available at baseline (2011); WHO Bioassay mortality to deltamethrin ranged from 1 to 100% (2011)
Kdr frequency by cluster ranged from 9 to 65% (2011)
WHO Bioassay mortality to deltamethrin ranged from 43 to 100% (2012)
Kdr frequency by cluster ranged from 44 to 93% (2011)
WHO Bioassay mortality to deltamethrin ranged from 20 to 100% (2011)
WHO Bioassay mortality to deltamethrin ranged from 86 to 100%; WHO Bioassay mortality to bendiocarb ranged from ranged from 27 to 98%
PfPR 2–10 Endemcity classa
In Sudan and India clusters were randomized to receive either universal coverage with ITNs alone or IRS plus universal coverage of ITNs in combination. This allowed an additional evaluation to be conducted, the comparison of the combined use of IRS and ITNs with ITNs alone, in varying resistance settings. In Sudan, this randomization was restricted in such a way that the baseline frequency of genotypic IR in local vector populations was approximately equal in the two study arms, based on molecular analysis of local mosquitoes caught in each cluster at baseline . In India, randomization was carried out separately in strata defined by the median of standard bioassay mortality of Anopheles culicifacies to bendiocarb, carried out during baseline entomological surveys in each study cluster.
All variables (outcome, exposure and confounders) were measured in each study cluster at different time points and analysis took account of the time dependent nature of the measurements. Although separate analyses are planned for each country, the statistical methodology described below is consistent across all countries.
For infection incidence (infection detection cohorts) and case incidence (case detection cohorts), incidence was estimated as the number of incident cases per child year of follow-up. Incidence RRs (or hazard ratios where appropriate) were calculated per 1% change in cluster specific vector susceptibility (mosquito mortality) or as incidence RRs in high resistance clusters, relative to low resistance clusters. Multiple variable Poisson or Cox regression was used to adjust estimated effects for measured potential confounders where appropriate. For cross-sectional prevalence of infection data, logistic regression was used to estimate odds ratios, again per % change in cluster specific mosquito mortality or comparing prevalence in high versus low resistance clusters. All estimates of epidemiological outcomes used statistical methods that took account of the variation between clusters by either using random effects models, or the first-order Taylor-series linearization method as a robust variance estimator to calculate appropriate standard errors [32, 33].
When resistance was analysed as a dichotomous variable (‘high’ versus ‘low’ resistance), the median phenotypic and/or genotypic resistance value for all clusters was used as the cut-point, with each cluster classified as low or high resistance depending on which side of the cut-point it fell. Fixed definitions such as the WHO definition of susceptibility  of a minimum threshold of 98% mortality in bioassay tests were not used, since there were generally too few or no clusters with susceptibility according to this definition. Moreover, such predefined thresholds do not necessarily reflect operational failure. Whether the relationship between case incidence and resistance was linear could not be pre-defined; therefore analyses using resistance as categorical and continuous variables were carried out.
Tabulation of hypothetical data on incidence by active case detection in high and low resistance clusters, showing loss of effectiveness of second intervention (IRS)
Incidence (cases per 1,000 person years)
Rate ratio (LLIN + IRS versus LLIN)
Change in effectiveness ratio (high versus low resistance)
LLIN + IRS
LLIN + IRS
2.0 [95% CI 1.1–5.0; p = 0.04]
For Approach 2, effectiveness of LLINs was calculated as an odds ratio for infection prevalence between net users and non-users, in high and low resistance clusters, respectively. Effectiveness odds ratios were compared through an interaction term in the model as a ratio of the two odds ratios. A similar analysis was carried out using incidence rate ratios for comparing incidence rates in users and non-users of ITNs.
Hypothetical illustration of infection prevalence by ITN use and by resistance stratum demonstrating loss of effectiveness expressed as an odds ratio
Deltameth. resistance (2012) of clusters (no. of clusters)
Infection prevalence, % (N)
Effect modification of resistance on effectiveness
Odds ratio ITN-use versus no net use
Change in effectiveness ratio, (high versus low resistance)
Low resistance (mortality ≥80%)
High resistance (mortality <80%)
Previous research on IR has generally been restricted to entomological outcomes. As a consequence there is little guidance on what the magnitude of its effect on malaria incidence is likely to be. Quantifying the health impact of IR is challenging, as no random allocation of the exposure is possible. A possible alternative design would have been to randomly allocate treated and untreated nets to populations in areas of known IR to see whether the treated nets still conferred additional protection compared to untreated nets. This would be based on the assumption that ITNs in the presence of resistance are, at worst, equivalent to untreated nets. A recent meta-analysis of entomological studies on pyrethroid resistance  concluded that ITNs are more effective against malaria than untreated nets, regardless of resistance. It would therefore be unethical to randomize individuals to receive either insecticide-treated vector control tools (ITNs) or untreated nets.
It is not known whether resistant mosquitoes are as competent as susceptible mosquitoes as vectors of malaria. If resistant mosquitoes are less efficient vectors, as seen in a study of filariasis transmission , this effect could partially offset any loss of effectiveness of vector control due to IR. This study will only be able to measure the overall impact of IR in malaria vectors on vector control, without disentangling the separate effects of increased survival and possible loss of vector competence.
The results of an observational study may be subject to confounding. A way of guarding against this is through adjustment in the analysis for known confounders although this does not provide a guarantee against unknown and unobserved confounders. Nevertheless, well-designed, non-randomized, observational, epidemiological studies using long-term follow-up of cohorts have convincingly shown the effects of exposures that are harmful to human health, e.g., smoking , as well as exposures that are beneficial, e.g., physical exercise . When such studies are ‘ecological’ studies because they rely on associations at community rather than individual level, an additional layer of complexity is involved. The association between the outcome (e.g., malaria incidence/prevalence) and an exposure (e.g. IR) at area level is sometimes referred to as ecological inference  and can be subject to hidden confounding unless the association is also true at individual level. In this case there was no means of verifying an association between individual incident malaria cases and individual resistant mosquitoes.
Further challenges were the collection of malaria incidence data in countries where reporting systems are weak, and difficulties collecting sufficient mosquito larvae from each cluster for susceptibility testing. It was necessary to set up active case detection cohorts for the measurement of incidence, which is logistically challenging and requires intense supervision. Measuring IR in many locations is also challenging and requires standardization of procedures and testing conditions such as temperature and humidity. There are more sensitive methods of resistance determination such as generation of population specific concentration or lethal exposure time curves [24, 38]. However these better metrics of the intensity of IR require multiple exposures per cluster which was not possible in logistically constrained study settings. The WHO susceptibility test measuring mosquito mortality within 24 h after 60 min of exposure to a standard concentration of insecticide on impregnated papers is commonly used and was considered operationally the most feasible.
The second approach described above, in which loss of effectiveness is measured as the ratio of odds ratios (interaction) in users and non-users of nets in high and low resistance clusters, respectively, has the advantage that the non-ITN users serve as a reference group. The drawback is that ITN use was not randomly allocated to individuals and hence there are major confounders affecting the relationship between infection prevalence and ITN use. Very often ITN use is greatest amongst people with highest risk. For example, according to the 2014 World Malaria Report  pregnant women and children were more likely than the general population to sleep under an ITN since net distribution campaigns often target these groups. This in turn may lead to apparently higher malaria prevalence overall amongst ITN users than non-users. As a result it will appear as if ITNs are ineffective. An additional problem with this approach is that reported net use (whether accurate or not) is often very high in cohorts where the standard question of net-use last night is asked at every visit. As a result, the non-user comparison group is very small and probably unrepresentative, leading to a biased estimate.
Despite these challenges, this study will generate approximately 300 observations of malaria incidence in communities protected by LLINs (in some instances in combination with IRS), and concomitant IR across multiple time points and transmission settings. If IR has a profound impact on the effectiveness of these interventions, an association between these two measures should be evident. The advantage of the chosen design is that the formation of many study clusters results in a relatively large sample of independent paired observations of IR and malaria incidence. The harmonization of methods across countries will provide the possibility of combining data across countries for analysis.
The historical data from South Africa  suggest as much as a ten-fold increase in malaria incidence if there is resistance to the IRS insecticide. On the other hand, studies comparing the effectiveness of ITNs and untreated nets  showed that untreated nets are approximately half as effective as treated nets in settings of insecticide susceptibility, suggesting a potential two-fold increase in malaria burden resulting from resistance to insecticides used on ITNs, other factors remaining the same. This study will be able provide some evidence based insights into this question.
The multi-country study described in this paper, despite many inherent challenges associated with study design and measurement of resistance, is unique in assembling a large data set of connected entomological and epidemiological observations. It will provide quantitative insights on the impact that IR has on the effectiveness of malaria vector control, and the potential for control programme failure. The findings will be important for determining the urgency with which management of IR should be undertaken, and the effort and investment that are required in the search for alternatives to current insecticide-based tools for the control and elimination of malaria.
IK, HTK, AIB, CM, JB, AA, RK, TBK, EM, ZJN, APM, and MJD designed the study. IK drafted the manuscript. MJD wrote the entomological sections and reviewed the whole manuscript. HTK, AIB, CM, JB, AA, RK, TBK, EM, ZJN, and APM reviewed and helped write the manuscript. All authors made intellectual input to the study. All authors read and approved the final manuscript.
Role of funding source
IK receives support from the Medical Research Council and Department for International Development (MR/K012126/1). This study was funded by the Bill and Melinda Gates Foundation (Grant Number 48499.01) and the World Heath Organisation. The study in Sudan was additionally part-funded by the Global Environmental Facility (Grant number GFL/4A2).
Compliance with ethical guidelines
Competing interests The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- WHO (2013) World malaria report 2013. World Health Organization, GenevaGoogle Scholar
- WHO (2014) World malaria report 2014. World Health Organization, GenevaGoogle Scholar
- WHO (2012) Global plan for insecticide resistance management in malaria vectors. World Health Organization, GenevaGoogle Scholar
- Sharp BL, Kleinschmidt I, Streat E, Maharaj R, Barnes KI, Durrheim DN et al (2007) Seven years of regional malaria control collaboration—Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg 76:42–47PubMed CentralPubMedGoogle Scholar
- Kleinschmidt I, Sharp B, Benavente LE, Schwabe C, Torrez M, Kuklinski J et al (2006) Reduction in infection with Plasmodium falciparum one year after the introduction of malaria control interventions on Bioko Island, Equatorial Guinea. Am J Trop Med Hyg 74:972–978PubMedGoogle Scholar
- Chanda E, Coleman M, Kleinschmidt I, Hemingway J, Hamainza B, Masaninga F et al (2012) Impact assessment of malaria vector control using routine surveillance data in Zambia: implications for monitoring and evaluation. Malar J 11:437PubMed CentralPubMedView ArticleGoogle Scholar
- Edi CVA, Koudou BG, Jones CM, Weetman D, Ranson H (2012) Multiple-insecticide resistance in Anopheles gambiae mosquitoes, Southern Cote d’Ivoire. Emerg Infect Dis 18:1508–1511PubMed CentralPubMedView ArticleGoogle Scholar
- Mitchell S, Stevenson B, Müller P, Wilding C, Yawson A, Field S et al (2012) Identification and validation of a gene causing cross-resistance between insecticide classes in Anopheles gambiae from Ghana. Proc Natl Acad Sci USA 109:6147–6152PubMed CentralPubMedView ArticleGoogle Scholar
- Mitchell SN, Rigden DJ, Dowd AJ, Lu F, Wilding CS, Weetman D et al (2014) Metabolic and target-site mechanisms combine to confer strong DDT resistance in Anopheles gambiae. PLoS One 9:e92662PubMed CentralPubMedView ArticleGoogle Scholar
- Maharaj R, Mthembu DJ, Sharp BL (2005) Impact of DDT re-introduction on malaria transmission in KwaZulu-Natal. S Afr Med J 95:871–874PubMedGoogle Scholar
- Hargreaves K, Koekemoer LL, Brooke BD, Hunt RH, Mthembu J, Coetzee M (2000) Anopheles funestus resistant to pyrethroid insecticides in South Africa. Med Vet Entomol 14:181–189PubMedView ArticleGoogle Scholar
- Barnes KI, Chanda P, Ab Barnabas G (2009) Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Malar J 8(Suppl 1):S8PubMed CentralPubMedView ArticleGoogle Scholar
- Sharp BL, Ridl FC, Govender D, Kuklinski J, Kleinschmidt I (2007) Malaria vector control by indoor residual insecticide spraying on the tropical island of Bioko, Equatorial Guinea. Malar J 6:52PubMed CentralPubMedView ArticleGoogle Scholar
- Hemingway J, Vontas J, Poupardin R, Raman J, Lines J, Schwabe C et al (2013) Country-level operational implementation of the Global Plan for Insecticide Resistance Management. Proc Natl Acad Sci USA 110:9397–9402PubMed CentralPubMedView ArticleGoogle Scholar
- Strode C, Donegan S, Garner P, Enayati AA, Hemingway J (2014) The impact of pyrethroid resistance on the efficacy of insecticide-treated bed nets against African anopheline mosquitoes: systematic review and meta-analysis. PLoS Med 11:e1001619PubMed CentralPubMedView ArticleGoogle Scholar
- WHO (2013) WHO recommendations for achieving universal coverage with long-lasting insecticidal nets in malaria control. World Health Organization, GenevaGoogle Scholar
- Hawley WA, Phillips-Howard PA, ter Kuile FO, Terlouw DJ, Vulule JM, Ombok M et al (2003) Community-wide effects of permethrin-treated bed nets on child mortality and malaria morbidity in western Kenya. Am J Trop Med Hyg 68:121–127PubMedGoogle Scholar
- Hayes RJ, Moulton LH (2009) Cluster randomised trials. CRC Press, Boca RatonView ArticleGoogle Scholar
- Roll Back Malaria Monitoring and Evaluation Reference Group (2005) Malaria Indicator Survey: HH Questionnaire, vol 2011. Roll Back Malaria Monitoring and Evaluation Reference GroupGoogle Scholar
- Walsh PS, Metzger DA, Higushi R (2013) Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 54:134–139PubMedGoogle Scholar
- WHO (2013) Test procedures for insecticide resistance monitoring in malaria vector mosquitoes. World Health Organization, GenevaGoogle Scholar
- Bagi J, Grisales N, Corkill R, Morgan JC, N’Fale S, Brogdon WG et al (2015) When a discriminating dose assay is not enough: measuring the intensity of insecticide resistance in malaria vectors. Malar J 14:210PubMed CentralPubMedView ArticleGoogle Scholar
- Toe KH, Jones CM, N’Fale S, Ismail HM, Dabire RK, Ranson H (2014) Increased pyrethroid resistance in malaria vectors and decreased bed net effectiveness, Burkina Faso. Emerg Infect Dis 20:1691–1696PubMed CentralPubMedView ArticleGoogle Scholar
- Muller P, Warr E, Stevenson BJ, Pignatelli PM, Morgan JC, Steven A et al (2008) Field-caught permethrin-resistant Anopheles gambiae overexpress CYP6P3, a P450 that metabolises pyrethroids. PLoS Genet 4:e1000286PubMed CentralPubMedView ArticleGoogle Scholar
- Brogdon W, Chan A (2010) Guideline for evaluating insecticide resistance in vectors using the CDC bottle bioassay [with inserts 1 (2012) and 2 (2014)]. CDC. http://www.cdc.gov/malaria/features/bioassay.htm
- Ranson H, N’Guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V (2011) Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends Parasitol 27:91–98PubMedView ArticleGoogle Scholar
- Etang J, Fondjo E, Chandre F, Morlais I, Brengues C, Nwane P et al (2006) First report of knockdown mutations in the malaria vector Anopheles gambiae from Cameroon. Am J Trop Med Hyg 74:795–797PubMedGoogle Scholar
- Nwane P, Etang J, Chouasmall yi UM, Toto JC, Koffi A, Mimpfoundi R et al (2013) Multiple insecticide resistance mechanisms in Anopheles gambiae s.l. populations from Cameroon, Central Africa. Parasit Vectors 6:41PubMed CentralPubMedView ArticleGoogle Scholar
- Nwane P, Etang J, Chouasmall yi UM, Toto JC, Mimpfoundi R, Simard F (2011) Kdr-based insecticide resistance in Anopheles gambiae s.s populations in. BMC Res Notes 4:463PubMed CentralPubMedView ArticleGoogle Scholar
- Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, Johnston GL et al (2011) A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J 10:378PubMed CentralPubMedView ArticleGoogle Scholar
- Sismanidis C, Moulton LH, Ayles H, Fielding K, Schaap A, Beyers N et al (2008) Restricted randomization of ZAMSTAR: a 2 × 2 factorial cluster randomized trial. Clin Trials 5:316–327PubMedView ArticleGoogle Scholar
- Rao JNK, Scott AJ (1981) The analysis of categorical data from complex sample surveys: Chi squared tests for goodness of fit and independence in two-way tables. J Am Stat Assoc 76:221–230View ArticleGoogle Scholar
- Stata Corporation (2011) Stata survey data reference manual: release 12. Stata Press, College StationGoogle Scholar
- McCarroll L, Hemingway J (2002) Can insecticide resistance status affect parasite transmission in mosquitoes? Insect Biochem Mol Biol 32:1345–1351PubMedView ArticleGoogle Scholar
- Doll R, Peto R (1976) Mortality in relation to smoking: 20 years’ observations on male British doctors. BMJ 2:1525–1536PubMed CentralPubMedView ArticleGoogle Scholar
- Davey Smith G, Shipley MJ, Batty GD, Morris JN, Marmot M (2000) Physical activity and cause-specific mortality in the Whitehall study. Public Health 114:308–315PubMedView ArticleGoogle Scholar
- Schwartz S (1994) The fallacy of the ecological fallacy: the potential misuse of a concept and the consequences. Am J Public Health 84:819–824PubMed CentralPubMedView ArticleGoogle Scholar
- Mawejje HD, Wilding CS, Rippon EJ, Hughes A, Weetman D, Donnelly MJ (2013) Insecticide resistance monitoring of field-collected Anopheles gambiae s.l. populations from Jinja, eastern Uganda, identifies high levels of pyrethroid resistance. Med Vet Entomol 27:276–283PubMed CentralPubMedView ArticleGoogle Scholar
- Lengeler C (2004) Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev 2:CD000363PubMedGoogle Scholar